These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29532425)

  • 1. Biowaiver or Bioequivalence: Ambiguity in Sildenafil Citrate BCS Classification.
    Miranda C; Pérez-Rodríguez Z; Hernández-Armengol R; Quiñones-García Y; Betancourt-Purón T; Cabrera-Pérez MÁ
    AAPS PharmSciTech; 2018 May; 19(4):1693-1698. PubMed ID: 29532425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements.
    Davit BM; Kanfer I; Tsang YC; Cardot JM
    AAPS J; 2016 May; 18(3):612-8. PubMed ID: 26943914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil Hydrochloride BCS Class Ambiguity: Relevant Aspects to be Considered in Drug Classification.
    de Campos DP; Silva-Barcellos NM; Caldeira TG; Mussel WDN; Silveira V; de Souza J
    J Pharm Sci; 2022 Nov; 111(11):3064-3074. PubMed ID: 35787368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluisio experimental approaches.
    Lozoya-Agullo I; Zur M; Wolk O; Beig A; González-Álvarez I; González-Álvarez M; Merino-Sanjuán M; Bermejo M; Dahan A
    Int J Pharm; 2015 Mar; 480(1-2):1-7. PubMed ID: 25595387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System-Biowaiver.
    Plöger GF; Hofsäss MA; Dressman JB
    J Pharm Sci; 2018 Jun; 107(6):1478-1488. PubMed ID: 29421214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests.
    Kim JS; Mitchell S; Kijek P; Tsume Y; Hilfinger J; Amidon GL
    Mol Pharm; 2006; 3(6):686-94. PubMed ID: 17140256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.
    Parr A; Hidalgo IJ; Bode C; Brown W; Yazdanian M; Gonzalez MA; Sagawa K; Miller K; Jiang W; Stippler ES
    Pharm Res; 2016 Jan; 33(1):167-76. PubMed ID: 26286187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro and In Situ Characterization of Triterpene Glycosides From Cimicifuga racemosa Extract.
    Disch L; Forsch K; Siewert B; Drewe J; Fricker G
    J Pharm Sci; 2017 Dec; 106(12):3642-3650. PubMed ID: 28827038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation.
    Zur M; Hanson AS; Dahan A
    Eur J Pharm Sci; 2014 Sep; 61():11-7. PubMed ID: 24262076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopharmaceutics classification system: the scientific basis for biowaiver extensions.
    Yu LX; Amidon GL; Polli JE; Zhao H; Mehta MU; Conner DP; Shah VP; Lesko LJ; Chen ML; Lee VH; Hussain AS
    Pharm Res; 2002 Jul; 19(7):921-5. PubMed ID: 12180542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats.
    Li H; Dong L; Liu Y; Wang G; Wang G; Qiao Y
    Int J Pharm; 2014 May; 466(1-2):133-8. PubMed ID: 24607203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FDA should eliminate the ambiguities in the current BCS biowaiver guidance and make public the drugs for which BCS biowaivers have been granted.
    Benet LZ; Larregieu CA
    Clin Pharmacol Ther; 2010 Sep; 88(3):405-7. PubMed ID: 20668447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the full potential of the biopharmaceutics classification system reached?
    Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
    Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
    Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
    Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification.
    Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL
    Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Isavuconazonium Sulfate.
    Plano D; Rudolph N; Saal C; Abrahamsson B; Cristofoletti R; Kambayashi A; Langguth P; Mehta M; Parr A; Polli JE; Shah VP; Charoo N; Dressman J
    J Pharm Sci; 2024 Feb; 113(2):386-395. PubMed ID: 37951471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
    Cristofoletti R; Chiann C; Dressman JB; Storpirtis S
    J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCS-based biowaivers: Extension to paediatrics.
    Martir J; Flanagan T; Mann J; Fotaki N
    Eur J Pharm Sci; 2020 Dec; 155():105549. PubMed ID: 32941998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutics classification and intestinal absorption study of apigenin.
    Zhang J; Liu D; Huang Y; Gao Y; Qian S
    Int J Pharm; 2012 Oct; 436(1-2):311-7. PubMed ID: 22796171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.